GAITHERSBURG, Md., March 11, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that it has dosed the first participant in its…
The Bethesda-based developer is preparing two developments under the moniker "EvolutionLabs" to take advantage of the growing life sciences demand in the…
Casimir Further Differentiates Emmes' Industry-Leading Rare Disease Research Capabilities ROCKVILLE, Md., March 10, 2022 /PRNewswire/ -- Emmes, a global, full-service…
Indeed, in 2021, the U.S. bioscience industry represents a unique confluence of characteristics essential for addressing these challenges and realizing…